Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.3 is now displayed on the page, replacing the prior Revision: v3.4.2. This update concerns revision history metadata and does not alter the study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRemoved the old government funding operating-status notice and the prior Revision: v3.4.1; added Revision: v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check38 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, informing users that information may not be up to date and the NIH Clinical Center is open with status updates at opm.gov. The page version indicator was updated to Revision: v3.4.1 and the previous Revision: v3.4.0 was removed.SummaryDifference0.4%

- Check45 days agoChange DetectedGlossary toggle is now visible on the page. The page now displays a 'Last Update Submitted that Met QC Criteria' label, includes a 'No FEAR Act Data' notice, and shows 'Revision: v3.4.0' in the footer.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 removed. This is a minor site update with no changes to trial details.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a Locations section with Massachusetts and updated page revision to v3.3.3. The old Massachusetts Locations label and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.